Intellia Therapeutics Aktie
22,23
EUR
+0,43
EUR
+1,97
%
25,94
USD
+0,07
USD
+0,25
%
Werbung
Intellia Therapeutics Aktie Analyse
| 02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung